Transgenomic (TBIO) Reports Q1 Loss Per Share of $0.36

Transgenomic (NASDAQ: TBIO) reported Q1 EPS of ($0.36), versus ($0.60) reported last year. Revenue for the quarter came in at $6.51 million, versus $62.5 million reported last year.

For earnings history and earnings-related data on Transgenomic (TBIO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc. (XP) Tops Q2 EPS by 8c
• InspireMD (NSPR) Tops Q2 EPS by 1c